Gene: PECR
Official Full Name: peroxisomal trans-2-enoyl-CoA reductaseprovided by HGNC
Gene Summary: Enables signaling receptor binding activity and trans-2-enoyl-CoA reductase (NADPH) activity. Involved in phytol metabolic process. Located in peroxisome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15240 | PECR Knockout cell line (HeLa) | Human | PECR | 1:3~1:6 | Negative | Online Inquiry |
KO15241 | PECR Knockout cell line (HCT 116) | Human | PECR | 1:2~1:4 | Negative | Online Inquiry |
KO15242 | PECR Knockout cell line (HEK293) | Human | PECR | 1:3~1:6 | Negative | Online Inquiry |
KO15243 | PECR Knockout cell line (A549) | Human | PECR | 1:3~1:4 | Negative | Online Inquiry |
PECR Gene Knockout Cell Lines are precision-engineered cellular models specifically designed to facilitate the study of the peroxisomal trans-2-enoyl-CoA reductase (PECR) gene. This gene is crucial for lipid metabolism, particularly in the synthesis of fatty acids and other essential biomolecules. By creating knockout cell lines where the PECR gene has been inactivated, researchers are able to assess the functional consequences of its loss and explore its role in various metabolic pathways, offering insights into cellular energy homeostasis and disease mechanisms.
The key function of these knockout cell lines arises from their ability to reveal the impacts of PECR deficiency on cellular processes such as fatty acid oxidation and lipogenesis. By utilizing these models, scientists can elucidate the biochemical pathways impacted by PECR in conditions such as metabolic syndrome and mitochondrial dysfunction. Additionally, these cell lines serve as powerful tools for drug discovery and development, enabling the identification of therapeutic targets and the testing of potential pharmacologic interventions aimed at modulating lipid metabolism.
The scientific importance of PECR Gene Knockout Cell Lines is particularly pronounced in both research and clinical settings. They are invaluable in the study of metabolic diseases, allowing for the validation of hypotheses regarding lipid dysregulation, and they provide a platform for translational research that bridges the gap between basic science and clinical application. In comparison to other genetic manipulation technologies, such as CRISPR-Cas9, our knockout cell lines offer a pre-validated and ready-to-use solution that accelerates research timelines without necessitating additional genome-editing workflows.
Researchers and clinicians will find immense value in these cell lines as they provide a reproducible and reliable model for studying complex biological phenomena. The commitment to rigorous quality control and the provision of comprehensive customer support underscore our dedication to empowering scientific discovery.
With expertise in cellular biology and genetic engineering, our company specializes in the development and provision of advanced biological products, ensuring that researchers have access to tools that drive innovation and enhance understanding within the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.